Find out about the trial its history and the team
Recruitment, press and media and early results
Downloads, videos, advice and information.
Call us, email us, follow on Twitter & YouTube
The trial will only succeed with a lot of involvement from
healthcare professionals around the world. If you are a health care
professional and would like to be involved then fill in the form
below and we will contact you as soon as we are ready.
To show interest in the trial please enter your details below.
Prof Sir John Burn's expert views on aspirin included in an
article in The Mail on Sunday dated August 19, 2012
CaPP3: progress towards a launch in 2013
Research has finally provided proof that taking a regular dose
of aspirin reduces the long-term risk of cancer in people with a
family history of the disease by around 60 per cent.
Institute of Genetic Medicine
International Centre for Life
Newcastle upon Tyne, NE1 3BZ
CAPP3 © 2011 | Web Development by Chocolate Grape